DALCOR PHARMA LICENSES A LATE-STAGE INVESTIGATIONAL CARDIOVASCULAR DRUG FOLLOWING MAJOR SCIENTIFIC DISCOVERY New company DalCor to sponsor global phase III clinical trial San Mateo, California, June 8, 2015 – DalCor Ph

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 49,75 KB